Novo Nordisk's Weight Loss Drug Ozempic Associated With Reduced Opioid, Alcohol Use Disorder Incidences, Study Shows
A study found that prescriptions for GIP/GLP-1 RA drugs may reduce opioid overdose and alcohol intoxication rates in patients with OUD and AUD, offering potential new treatments for addiction.
In 2005, Bernalillo County implemented a program that allowed people to get treatment for opioid use disorder while ...
The progress made to mitigate the opioid use crisis still pales in comparison with the crucial effort needed to address it, ...
Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, ...
The research, published in the monthly scientific journal Addiction, found that among people with opioid use disorder, ...
New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people ...
News Medical on MSN1d
Glucagon-like peptide-1 receptor agonists may be new treatment for opioid and alcohol use disorder, finds studyOzempic is one of several medications, called glucagon-like peptide-1 receptor agonists or GLP-1 RAs, that are prescribed to ...
Naltrexone (referred to as the "Ozempic of alcohol") is a drug that can help reduce alcohol and opioid cravings for people ...
Diabetes and weight loss drugs like Mounjaro and Ozempic may also help patients suffering from addiction, according to a new ...
Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...
The state of Michigan is set to receive over $109 million over the next three years to address substance use disorder.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback